← FDA Drug Approvals (Drugs@FDA)

TYRUKO

BLA · Biologics License Application · Sponsor: SANDOZ INC · Approved 2023-08-24

Drug application

FDA Application #

BLA761322

Application type

Biologics License Application

Brand name

TYRUKO

Generic name

NATALIZUMAB-SZTN

Active ingredients

NATALIZUMAB-SZTN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SANDOZ INC

Manufacturer

Sandoz Inc

First approval

2023-08-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown